Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
64.00    1.00 (1.59%)
Bid:
62.00
Ask:
63.50
Spread: 1.50 (2.419%)
Market Cap: £5.88m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Stabilisation Notice

19 Mar 2010 07:00

RNS Number : 8458I
CPPGroup PLC
19 March 2010
 



 

 

 

TO BE RELEASED OUTSIDE THE UNITED STATES ONLY. NOTFOR DISTRIBUTION DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, AUSTRALIA,CANADA, SWITZERLAND, SOUTH AFRICA OR JAPAN

 

FOR IMMEDIATE RELEASE 19 MARCH 2010

Stabilisation Notice: CPPGroup Plc

 

In connection with the Global Offer in relationto the following Ordinary Shares:

CPPGroup Plc Ordinary Shares of 10p each

ISIN Code: GB00B5W55H93

 

Pursuant to Rule 3070 of the Rules of the LondonStock Exchange, UBS Limited hereby notifies the London Stock Exchange that, as stabilising manager,either it or its agents may over-allot and/or effect other transactions with a viewto supporting the market price of the Ordinary Shares of CPPGroup Plc ("OrdinaryShares") at a level higher than that which might otherwise prevail from 8:00a.m.on 19 March 2010 to close of business on 16 April 2010.However, there is no obligation on UBS Limited, or any agent of UBS Limited,to do thisand there is no assurance that stabilising transactionswill be undertaken. Such transactions may be effected onthe London Stock Exchange, any over the counter market, other stock exchange or otherwise.Such stabilising, if commenced, may be discontinued at any time withoutprior notice and must be brought to an end no laterthan 16 April 2010. In no event will measures betaken to stabilise the market price of the Ordinary Shares above the issue priceof 235p. Save as required by law or regulation, neither UBS Limited nor any of itsagents intends to disclose the extent of any over-allotments made and/or stabilisationtransactions conducted in relation to the Global Offer.

 

In connection with the Global Offer, Hamish Ogston(as Over-allotment Shareholder), has granted UBS Limited, on behalf of itself andJ.P. Morgan Securities Limited, an Over-allotment Option, exercisable in whole orin part upon notice by UBS Limited on or before 16 April 2010 which, if exercisedwill require the Over-allotment Shareholder to sell up to 10 per cent. of the aggregatenumber of Ordinary Shares available in the Global Offer (before any exercise of theOver-allotment Option) at the Offer Price to cover short positions arising from anyover-allotments and/or sales of Ordinary Shares effected by UBS Limited during thestabilising period.

 

Any Over-allotment Shares made available pursuantto the Global Offer will rank pari passuin all respects with any Ordinary Shares being sold in the Global Offer and willbe purchased on the same terms and conditions as the other Ordinary Shares beingissued or sold in the Global Offer and will form a single class for all purposeswith the other Ordinary Shares.

 

UBS Limited has agreed with CPPGroup Plc that anyover-allotment of Ordinary Shares by it or any of its agents will be up to a maximumof 10 per cent. of the total number of Ordinary Shares comprised in the Global Offer(before any exercise of the Over-allotment Option).

 

Number of Ordinary Shares in the Global Offer: 63,829,786 (assuming no exercise of the over-allotment option)

Number of Ordinary Shares subject to the over-allotmentoption: 6,382,978

The issue price of CPPGroup Plc Ordinary Sharesof 10p each was set at 235p on 18 March 2010

 

UBS Limited contacts:

 

Sam Kendall

020 7568 3506

 

Edward Cook

020 7568 2227

 

 

IMPORTANT NOTICE

 

This announcement and the offer of the securitiesto which it relates are only addressed to and directed at persons outside the UnitedKingdom and persons in the United Kingdom who have professional experience in mattersrelated to investments or who are high net worth persons within article 12(5) ofthe Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 andmust not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not for publication or distribution,directly or indirectly, in or into the United States. The distribution of this announcementmay be restricted by law in certain jurisdictions and persons into whose possessionany document or other information referred to herein comes should inform themselvesabout and observe any such restriction. Any failure to comply with these restrictionsmay constitute a violation of the securities laws of any such jurisdiction.

 

J.P. Morgan Securities Limited and UBS Limited (together,the "Banks") are acting as joint sponsors, joint lead managers, joint global co-ordinatorsand joint bookrunners in connection with Admission and the Global Offer and as underwritersin connection with the Global Offer.

 

The Banks are acting exclusively for the Companyand no-one else in connection with the Global Offer. They will not regard any otherperson as their client in relation to the Global Offer and will not be responsibleto anyone other than the Company for providing the protections afforded to customersof the Banks or for giving advice in relation to the Global Offer, the contents ofthis announcement or any transaction, arrangement or other matter referred to herein. 

 

This announcement does not contain or constitutean offer, or the solicitation of an offer to buy or subscribe for Ordinary Shares,and is not for distribution in, the United States, Canada, Australia, Switzerland,South Africa or Japan, or in any jurisdiction in which distribution is unlawful.The Ordinary Shares have not been and will not be registered under the US SecuritiesAct of 1933, as amended (the "Securities Act") or under the securities laws ofSouth Africa, Canada, Switzerland, Australia or Japan, and may not be offered, sold,transferred or delivered, directly or indirectly, in or into the United States exceptpursuant to an exemption from, or in a transaction not subject to, the registrationrequirements of the Securities Act and in compliance with any applicable securitieslaws of any states or other jurisdiction of the United States. Subject to certainexceptions, the Ordinary Shares referred to herein may not be offered or sold inSouth Africa, Canada, Switzerland, Australia or Japan, or to, or for the accountor benefit of any national, resident or citizen of South Africa, Canada, Switzerland,Australia or Japan. There will be no public offer of the Ordinary Shares in the UnitedStates, South Africa, Canada, Switzerland, Australia, Japan or elsewhere. Any failureto comply with these restrictions may result in a violation of the laws of such jurisdiction.

 

This announcement is for information purposes onlyand does not constitute an invitation or offer to underwrite, subscribe for or otherwiseacquire or dispose of any securities of CPPGroup Plc in any jurisdiction.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAKKCDPBBKKDND
Date   Source Headline
23rd Apr 20247:00 amRNSBlock listing Interim Review
3rd Apr 202410:29 amRNSPosting of Annual Report and Notice of AGM
26th Mar 20247:00 amRNSFULL YEAR RESULTS FOR YEAR ENDED 31 DECEMBER 2023
20th Mar 20242:12 pmRNSInvestor presentation via Investor Meet Company
15th Feb 20242:31 pmRNSDivestment of minority holding in KYND Limited
22nd Jan 20247:00 amRNSTrading Update for Financial Year 2023
11th Jan 20247:00 amRNSBlink progress in 2023
21st Dec 20237:00 amRNSBlock Listing of Ordinary Shares
20th Dec 20237:00 amRNSBlink Parametric signs Blue Cross extension
18th Dec 20237:00 amRNSBlock listing Interim Review and Cancellation
27th Nov 20237:00 amRNSGlobiva Divestment
2nd Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSBlink Parametric new client wins
25th Oct 20231:59 pmRNSBlock listing Interim Review
6th Oct 20237:00 amRNSBoard Update
2nd Oct 20237:00 amRNSResponse to press article
28th Sep 20233:03 pmRNSDirector/PDMR Shareholding
28th Sep 20237:00 amRNSAwards under Long Term Incentive Plan
19th Sep 20237:00 amRNSHalf-year Report for 6 months ended 30 June 2023
19th Sep 20237:00 amRNSStatement regarding change of website address
15th Sep 20237:00 amRNSInvestor presentation via Investor Meet Company
18th Jul 20237:00 amRNSTrading Update for six months ended 30 June 2023
26th Jun 20239:00 amRNSBlink Parametric new client wins
20th Jun 20237:00 amRNSBlock listing Interim Review
12th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:00 amRNSHolding(s) in Company
6th Jun 20239:34 amRNSHolding(s) in Company
31st May 20237:00 amRNSDirector/PDMR Shareholding
26th May 20233:17 pmRNSDirector/PDMR Shareholding
10th May 20237:00 amRNSResult of AGM
25th Apr 20237:00 amRNSBlock listing Interim Review
4th Apr 202312:36 pmRNSPosting of Annual Report and Notice of AGM
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSHolding(s) in Company
28th Mar 20232:40 pmRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSFULL YEAR RESULTS FOR YEAR ENDED 31 DECEMBER 2022
16th Feb 20237:00 amRNSBlink Parametric wins new partnerships
10th Feb 20237:00 amRNSHolding(s) in Company
24th Jan 20233:56 pmRNSStatement regarding share price movement
19th Jan 20237:00 amRNSTrading Update for Financial Year 2022
20th Dec 20227:00 amRNSBlock listing Interim Review
28th Nov 20223:52 pmRNSDirector/PDMR Shareholding
16th Nov 202211:46 amRNSDirector/PDMR Shareholding
10th Nov 202211:00 amRNSBlink Parametric wins global travel sector awards
3rd Nov 20227:00 amRNSTotal Voting Rights
25th Oct 20227:00 amRNSBlock listing Interim Review
21st Oct 20227:00 amRNSDisposal of Mexican legacy business
19th Oct 20227:00 amRNSStrategy and Change Management Programme
17th Oct 20227:00 amRNSHolding(s) in Company
26th Sep 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.